Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 63.4B | 54.5B | 117.5B | -11.8B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 14.0B | 16.3B | 35.9B | -10.1B |
Other operating expenses | 14.5B | 7.7B | 26.5B | -10.5B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 21.5B | 17.1B | 39.6B | -1.5B |
Tax provision | 6.2B | 3.4B | 11.1B | -1.4B |
Net income | 15.3B | 13.6B | 28.5B | -56.8M |
Basic EPS | 5 | — | — | — |
Diluted EPS | 5 | — | — | — |
Basic average shares | 3.1B | — | — | — |
Diluted average shares | 3.1B | — | — | — |
EBITDA | — | — | — | — |
Net income from continuing op. | 21.5B | 17.1B | 19.5B | 18.6B |
Minority interests | -25.7M | 82.4M | -13.5M | -132.3M |
Preferred stock dividends | — | — | — | — |